Elias David-Neto

• Abstract

  For the treatment of osteoporosis in the general population, a number of drugs reduce BMD (bone mineral density) loss and the rate of incident fractures. For instance, bisphosphonates improve BMD, reduce hip fracture rates and decrease mortality in post-menopausal women. Because of lack of data on safety and an increased risk of adverse effects, the use of these drugs is controversial in …

  A prospective and randomized trial of zoledronic acid to prevent bone loss in the first year after kidney transplantation, AP.R

• Abstract

  CMV disease is a challenge to the success of renal transplantation. Recently, we analyzed data from 792 renal transplant recipients performed at our hospital between 1999 and 2005. After the usual exclusions, 663 patients were analyzed. This population showed that the incidence of CMV disease is stable and occurs in approximately 20-22% of all patients and invasive disease in approximatel…

  Definition of cut off levels for PCR - quantitative and antigenemia in the diagnosis of cytomegalovirus (CMV) disease in serum-positive kidney transplant recipients, AP.R
• A prospective, randomized, controlled study using oral GTT to diagnose impaired glucose metabolism in renal transplant patients under cyclosporin-a and tacrolimus, AR.EXT

(Only some records are available in English at this moment)